Integrated Nanotherapeutics
PrivateLast Round
Grant
Mar 18, 2026
Total Funding Raised
$890,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Integrated Nanotherapeutics operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a Grant round in March 2026.
Integrated Nanotherapeutics is a biotechnology company that develops antigen-specific immune tolerance therapeutics using a proprietary multi-cargo lipid nanoparticle platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Integrated Nanotherapeutics Comparables
Compare Integrated Nanotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evoq Therapeutics | 88% | |
| Parvus Therapeutics Inc. | 82% | |
| Cour Pharma | 82% |
For institutional investors. Book with your work email.
Integrated Nanotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 18, 2026 | ||||
| Grant | Sep 9, 2024 | ||||
| Accelerator | Jun 1, 2023 | ||||
| Accelerator | Apr 1, 2023 | ||||
| Grant | Mar 18, 2019 |
For institutional investors. Book with your work email.
Integrated Nanotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Western Economic Diversification Canada | Grant |
| Genome British Columbia | Grant |
| Creative Destruction Lab | Accelerator |
| National Research Council Canada Industrial Research Assistance Program | Accelerator |
| JDRF | Grant |
| Life Sciences BC | Accelerator |
| UBC Investment Management | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors increased 90% MoM.
- Mar 18, 2026
Received grant funding from Genome British Columbia and Genome Canada.
For institutional investors. Book with your work email.
Integrated Nanotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Integrated Nanotherapeutics's valuation, stock price, and market status.
Is Integrated Nanotherapeutics a public or private company?
Integrated Nanotherapeutics is a private company.
What is the current stock price of Integrated Nanotherapeutics?
Integrated Nanotherapeutics is a private company, so its shares have no public market price. Caplight tracks Integrated Nanotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Integrated Nanotherapeutics worth (valuation)?
Valuation information for Integrated Nanotherapeutics is not publicly available.
Can I buy Integrated Nanotherapeutics stock?
Integrated Nanotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Integrated Nanotherapeutics's last funding round?
Integrated Nanotherapeutics's most recent funding round was Grant on March 18, 2026.
Who are the main investors in Integrated Nanotherapeutics?
Key investors in Integrated Nanotherapeutics include Western Economic Diversification Canada, Genome British Columbia, Creative Destruction Lab, National Research Council Canada Industrial Research Assistance Program, JDRF.
Will Integrated Nanotherapeutics IPO soon?
No public IPO plans have been announced for Integrated Nanotherapeutics.
How can I track Integrated Nanotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Integrated Nanotherapeutics's shares on secondary markets.